We are live on ! Find out more
CLSD

Clearside Biomedical
CLSD

Delisted

CLSD was delisted on the 28th of November, 2025.

Back to rankings

46 hedge funds and large institutions have $9.23M invested in Clearside Biomedical in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

258% more call options, than puts

Call options by funds: $118K | Put options by funds: $33K

38% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 8

35% more capital invested

Capital invested by funds: $6.82M → $9.23M (+$2.41M)

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

2% more funds holding

Funds holding: 45 → 46 (+1)

0% more ownership

Funds ownership: 0.84% → 0.84% (+0%)

Holders
46
Holders Change
+1
Holders Change %
+2.22%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
8
Closed
8
Calls
$118K
Puts
$33K
Net Calls
+$85K
Net Calls Change
+$80K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$115K
2
Renaissance Technologies
Renaissance Technologies
New York
+$106K
3
N
Natixis
France
+$45.2K
4
Millennium Management
Millennium Management
New York
+$32K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$29.6K

Top Sellers

Rank Fund Capital Flow
1
WIC
Water Island Capital
New York
-$71.8K
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$62.4K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$54.7K
4
S
SignatureFD
Georgia
-$47.1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$42.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wealth Enhancement Advisory Services
26
Wealth Enhancement Advisory Services
Minnesota
$23.4K – – –
XT
27
XTX Topco
Cayman Islands
$22.4K -$7.96K -558 -30%
Mariner
28
Mariner
Kansas
$22.2K +$18K +1,263 New
VF
29
Virtu Financial
New York
$20K +$16.7K +1,168 New
TRCT
30
Tower Research Capital (TRC)
New York
$16.4K +$3.02K +212 +29%
SWA
31
Stratos Wealth Advisors
Ohio
$16.4K – – –
Simplex Trading
32
Simplex Trading
Illinois
$13K +$6.32K +443 +137%
SPIA
33
Steward Partners Investment Advisory
New York
$12.9K – – –
Cambridge Investment Research Advisors
34
Cambridge Investment Research Advisors
Iowa
$12K -$5.7K -400 -36%
PNC Financial Services Group
35
PNC Financial Services Group
Pennsylvania
$6.54K – – –
JP Morgan Chase
36
JP Morgan Chase
New York
$3.75K +$29 +2 +0.9%
CG
37
Cutler Group
California
$2K – – –
Bank of America
38
Bank of America
North Carolina
$1.32K +$29 +2 +3%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$1.28K – – –
Osaic Holdings
40
Osaic Holdings
Arizona
$1.17K -$941 -66 -50%
HNB
41
Huntington National Bank
Ohio
$585 +$471 +33 New
Wells Fargo
42
Wells Fargo
California
$545 +$29 +2 +7%
SA
43
Scarborough Advisors
Maryland
$324 +$257 +18 New
CFD
44
Creative Financial Designs
Indiana
$117 +$100 +7 New
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$5 – – –
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$2 -$200 -14 Closed
WIC
47
Water Island Capital
New York
– -$71.8K -5,500 Closed
Assenagon Asset Management
48
Assenagon Asset Management
Luxembourg
– -$62.4K -4,785 Closed
Two Sigma Advisers
49
Two Sigma Advisers
New York
– -$54.7K -4,193 Closed
S
50
SignatureFD
Georgia
– -$47.1K -3,612 Closed
1
2
3

CLSD Hedge Fund Activity: Q4 2023 in Review

46 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Clearside Biomedical (CLSD) for Q4 2023, worth a combined $9.23M — up 35% from $6.82M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CLSD positions and 8 closed out — a net gain of 1 holder — while 11 added to existing stakes and 8 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $115K. The largest seller was Water Island Capital, exiting entirely with an estimated $71.8K sold.

  • 46 institutional investors held Clearside Biomedical (CLSD) as of Q4 2023, up from 45 in Q3 2023.
  • Funds reported $9.23M of Clearside Biomedical stock for Q4 2023, up 35% quarter-over-quarter.
  • 9 funds opened new Clearside Biomedical positions in Q4 2023 and 8 closed out, a net change of +1 holder.
  • The largest Clearside Biomedical buyer in Q4 2023 was Morgan Stanley, an estimated $115K added.
  • The largest Clearside Biomedical seller in Q4 2023 was Water Island Capital, an estimated $71.8K sold.

Based on aggregated 13F filings for Q4 2023.